ÂÜÀòÂÒÂ×

Andrew Farnum serves as the Chief Executive Officer of Variant Bio since April 2020 and holds a position on the Board of Directors for Inventprise starting in 2022. Previously, Andrew Farnum was a member of the Board of Directors for the Bill & Melinda Gates Medical Research Institute from 2018 to 2020 and contributed as the Director of the Gates Foundation Strategic Investment Fund from 2011 to 2020, overseeing a $2 billion investment fund. Earlier experience includes working as an Investment Manager at the Children's Investment Fund Foundation from 2008 to 2010. Andrew Farnum holds a Master of Public Administration in International Development from Harvard University and a Bachelor’s Degree in Molecular Biology from Princeton University.